Photocure ASA
OSE:PHO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Photocure ASA
OSE:PHO
|
NO |
|
T
|
Tirathai PCL
SET:TRT
|
TH |
|
Dal'nevostochnaya Energeticheskaya Kompaniya PAO
MOEX:DVEC
|
RU |
|
LightPath Technologies Inc
NASDAQ:LPTH
|
US |
|
C
|
Charoong Thai Wire & Cable PCL
SET:CTW
|
TH |
|
B
|
Bion Environmental Technologies Inc
OTC:BNET
|
US |
|
Nexcom A/S
F:8XT
|
DK |
Intrinsic Value
Is PHO undervalued or overvalued?
See the intrinsic value estimate for Photocure ASA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
PHO looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with PHO’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Photocure ASA Does
Photocure ASA is a medical technology company focused on bladder cancer. It sells a diagnostic drug used with a special blue-light camera system during cystoscopy, a procedure doctors use to look inside the bladder. The product helps urologists spot cancer tissue that can be harder to see under normal white light, so it is used in hospitals and specialty clinics that treat bladder cancer patients.
- Headquarters
- Norway NO
- Employees
- 102
- IPO date
- May 29, 2000
Revenue & Expenses Breakdown
Photocure ASA
Earnings Waterfall
Photocure ASA
The intrinsic value for Photocure ASA (PHO) under the Base Case is hidden NOK.
Compared with the current market price of 49.25 NOK, the stock appears hidden.